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CHAPTER ONE
REVIEW OF LITERATURE
T Cell Development
T cells, along with other mature immune cells, develop from hematopoietic stem cells
(HSCs) that reside in the bone marrow. Weissman et al. were the first group to identify these
bone marrow-derived progenitor cells, the common myeloid progenitor (CMP) and the common
lymphoid progenitor (CLP). CMP is the precursor for the development of all myeloid lineages,
which include megakaryocyte-erythrocyte progenitors, or granulocyte-macrophage progenitors1.
On the other hand, CLPs give rise to all lymphoid cells, including T cells, B cells, and natural
killer (NK) cells2. Both the common myeloid and the common lymphoid progenitors go on to
further differentiate into specific subsets of cells, forming the mature immune system.
The development of T cells specifically takes place within the thymus3,4, where double
negative (CD4- CD8-) precursor cells receive signals from stromal cells to differentiate5.
Rearrangement of the T cell receptor (TCR) occurs in an orderly fashion early in the
differentiation pathway, leading to a diverse repertoire of loci expressing either TCRgd or
TCRab with distinct variable regions6. The ability for T cells to continue to generate within the
thymus depends on the influx of stem cells from the bone marrow via blood, as stem cells in the
thymus have limited self-renewing ability7,8.
It was determined that the earliest progenitor cell can give rise to T, B, NK,
myeloid/granulocytic, and dendritic cells, and is dependent on the microenvironment in which
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they are found. These cells are called thymic multipotent precursors (TMPs) and mark the
branching point between T and B cell lineage9,10. Upon entering the thymus TMPs, which have
high levels of Notch receptors on their surface, must receive signals from Notch1 in order to
commit to the T cell lineage. At this point, the TMPs lose B cell potential and instead
differentiate into developing T cells10,11.
gd T Cell Development

Initially it was unclear how these thymic precursors differentiated into TCRab and
TCRgd lineages. Further research determined that the commitment to either ab or gd T cell
lineage occurs at the double negative (CD4- CD8-) stage in the thymus12. Although the exact
mechanisms are not fully understood yet, it has been found that SOX1313 (high-mobility group
transcription factor), as well as Id3 (Inhibitor of DNA binding 3)14, promotes the development of
gd T cells while also opposing commitment to the ab lineage. The strength of the TCR signal is
another factor that contributes to lineage determination, where strong signals promote gd
commitment, while weak signals promote ab commitment15.
gd T cell development involves the rearrangement of specific g and d gene segments
which appear in waves during ontogeny16,17. Once gd’s leave the thymus, most will localize to
non-lymphoid tissues which is based on the Vg chains they express18,19. While Vg influences
where in the body gd’s go, any functional differences between each subset of gd’s has not been
well studied. T cells with distinct combinations of Vg and Vd appear in 1 of 4 waves during
development. The first wave in the murine model occurs at embryonic day (ED) 14.5, in which
Vg5 and Vd1 is seen20. These T cells localize to the skin epidermis after development. The next
wave peaks around ED 16, when Vg6 is seen and later localizes to the uterus, lungs, and
tongue21. In the third wave (ED 18), Vg7 appears, although the exact timepoint is still unclear as
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of now23. Vg7 cells localized in gut mucosal tissues. The final wave (ED 20), is when Vg1 and
Vg4 appear and are later found in the periphery, including blood, spleen, and lymph nodes24,25.
When working with fetal mice, as was done in my thesis, it is important to understand this
developmental order and the presence of gd’s in the developing embryo.
ab T Cell Development

There is a lot more known about ab T cell development than gd T cell development,
providing us with a better understanding of the developmental process. During the double
negative (DN) stage within the thymus, TCRb, TCRg, or TCRd are rearranged, committing the
precursor cell to either the ab or gd lineage6,26. If TCRb chain is successfully rearranged, then
the pre-TCR complex is formed27,28, which consists of the rearranged TCRb chain and the preTCRa chain29. Signaling from the pre-TCR complex leads to many events that assist in the
further development of TCRab T cells, including a burst of proliferation with an upregulation of
CD4 and CD8 coreceptors. Along with this, the rearrangement of the TCRa gene is initiated,
while the TCRg gene is silenced30. Once the TCRa gene has been rearranged, the thymocytes
will become double positive (DP), expressing both CD4 and CD8 on their surface31.
Upon entering the double positive stage, the thymocytes will undergo positive and
negative selection. Positive selection occurs in the thymus cortex, where thymocytes that express
a TCR which recognizes self-MHC molecules are targeted32-34. This process is mediated by
cortical thymic epithelial cells, or cTECs, which will express a self-peptide in the context of
MHC class I or MHC class II. The determination of whether a thymocyte will survive, relies on
the strength of the TCR signal with the cTECs. If the TCR signaling is weak, then the survival of
that thymocyte is promoted. However, if there is strong TCR signaling, then the cell will undergo
activation induced apoptosis, which is the function of negative selection35. As implicated, the
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goal of negative selection is to remove any self-recognizing thymocytes. This occurs in the
medulla and is mediated by medullary thymic epithelial cells (mTECs) and dendritic cells (DCs).
Once surviving thymocytes have undergone positive selection, those that recognize major
histocompatibility complex (MHC), a group of genes encoding cell-surface proteins, class I will
become CD4- CD8+ single positive (SP) cells36. Thymocytes that recognize MHC class II
transition into CD4+ CD8- SP cells. Single positive thymocytes continue into their next stage of
development in which they undergo functional maturation. This involves the upregulation of
CD62L, S1P1, and CCR7, all of which help to facilitate the movement of these thymocytes into
circulation37,38. T cells that have left the thymus are then referred to as recent thymic emigrants,
and further continue their maturation within the periphery, eventually resulting in mature naïve
CD4+ and CD8+ T cells39,40. Besides gd and ab T cells, another important subset of T cells exists,
regulatory T cells.

Tregs
Treg Discovery
Regulatory T cells, or Tregs, are critical in maintaining immune homeostasis throughout
the body with their immunosuppressive effects. They function to prevent unwarranted and
excessive inflammation of tissues, as well as promote an adequate amount of self-tolerance. The
concept that the thymus generated some type of suppressor T cell was first introduced in the late
1960’s and early 1970’s when it was observed that following thymectomy of 3-day old neonatal
mice, the ovaries were subsequently destroyed, along with other tissues, leading to the idea of an
autoimmune-type disease as the cause41. Shortly after this, it was discovered that a subset of T
cells were found to dampen immune responses and was termed “suppressor T cells”42.
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The exploration of these cells was halted until the 1980’s, when studies into the role selftolerance played in autoimmune disease development led to the finding of T cells that had
autoimmune-suppressive activity43. With this finding, subsequent studies were performed, most
notable being a complete thymectomy followed by sublethal irradiation which resulted in
autoimmune thyroiditis and type I diabetes in adult rats44,45. Upon transfer of syngeneic T cells
into these rats, they were found to be protected from both thyroiditis and diabetes46,47. These
studies confirmed the existence of a group of T cells in the thymus that prevents autoimmune
disease.
In the 1990’s, suppressive CD4+ T cells were found to express the IL-2 receptor a-chain
(CD25)48. Upon depletion of these CD4+ CD25+ T cells, mice were observed to have
spontaneous development of autoimmune diseases, as well as an increased immune response to
foreign antigens. However, it was shown that if the CD4+ CD25+ T cells were reconstituted soon
after depletion, the mice did not develop any autoimmune diseases, and had normal response to
foreign antigens48. 3 days after birth, CD4+ CD25+ T cells are detected in the periphery of
neonates, which increases rapidly until they reach adult-like levels around 2 weeks after birth49.
However, if a neonatal thymectomy is performed around this 3-day mark, the presence of these
cells in the periphery is eliminated and autoimmune diseases are observed. The autoimmune
disease formation can be prevented however if CD4+ CD25+ T cells are transferred back into the
mice post-thymectomy49.
Types of Tregs
There are 3 different types of Tregs, thymic Tregs (tTregs), peripheral Tregs (pTregs),
and in vitro-induced Tregs (iTregs)50. As the name implies, thymic Treg generation occurs
within the thymus when thymocytes bind MHC-self peptides strongly and is mediated by
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mTECs that express Aire, an autoimmune regulator51. tTregs are important in maintaining selftolerance and assists in identifying any self-reactive T cells that have avoided negative selection.
pTregs are generated in the periphery when naïve CD4+ T cells are stimulated with cognate
antigens in the presence of transforming growth factor-b (TGF-b), retinoic acid, and IL-252,53.
These cells have been found to accumulate in areas that are exposed frequently to foreign
antigens, such as in the intestines, and help to control the immune response at these sites54,55.
iTregs can be induced from CD4+ T cells after TCR activation, and are useful in studying Tregs.
Mechanisms of Tregs
When the immune system becomes activated against a pathogen, it produces an
inflammatory response which can damage local tissues. These damaged tissues will then produce
anti-inflammatory cytokines, such as TGF-b, which induces Tregs at the site56,57. For Tregs to
have suppressive functions, they must first be TCR-activated in the presence of IL-258. Once
activated, they are then able to suppress other conventional-type T cells even without antigen
exposure, known as bystander suppression59.
There are multiple mechanisms in which Tregs function to maintain homeostasis. At a
site of inflammation, Tregs bind with high affinity to IL-2 which inhibits IL-2 availability,
consequently limiting CD8+ T cell activation and proliferation60. This dampens the cytotoxic
activity, promoting a decrease in the inflammatory response. Along with this, Tregs express
cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), which is a coinhibitory molecule that
modifies antigen presenting cell (APC) activity61,62,63. The expression of CTLA-4 downregulates
CD80 and CD86 which are found on APCs, such as dendritic cells, suppressing the proliferation
of conventional T cells64,65. Tregs also produce immunosuppressive cytokines themselves,
including TGF-b and IL-1066,67, as well as effector T cell transcription factors, like T-bet68.
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These mechanisms show the many ways in which Tregs can cause suppressive effects during
pathogen exposure and help to maintain a state of homeostasis. This is especially important in
sites that are constantly being exposed to antigens, like in the intestine. However, immediately
after birth, neonates do not have these protective cells, and so a gap in knowledge exists in what
kind, if any, cells are offering protection.
Foxp3
Forkhead box P3, or Foxp3, is a transcription factor that functions as the master regulator
of Tregs. Foxp3 was first discovered in 2001, when its single mutation in the X-chromosome
was linked to the cause of spontaneous and severe autoimmunity in Scurfy mice69. Around the
same time, it was discovered that a mutation in the human version of Foxp3 caused a similar
disease termed IPEX (immune dysregulation, polyendocrinopathy, enteropathy, x-linked
syndrome)70,71. The effects this mutation had rendered similar to that of mice deficient in Tregs,
leading to the hypothesis that Foxp3 is essential for the development and proper function of
Tregs. Studies on the relationship between Foxp3 and Tregs eventually showed that it was a
crucial factor in their generation and overall function72,73,74.
Along with the promoter at the Foxp3 gene locus, 3 conserved noncoding DNA
sequences (CNS) have been identified75. These are termed CNS1, CNS2, and CNS3, all of which
contribute to the differentiation of tTregs and pTregs. CNS1 is essential for both iTreg and pTreg
development, containing binding sites for different transcription factors, including Smad2 and
Smad376. Both Smad2 and Smad3 are necessary for the TGF-b-mediated induction of Foxp3 in
pTregs. The Smad family of proteins are essential in signal transduction for TGF-b receptors.
When CNS2 is demethylated, Foxp3 will bind to it and through a positive feedback loop, will
enhance its expression75. This occurs after demethylation of CpG sites on CNS2, further
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contributing to stable Foxp3 expression in tTregs77,78. The CNS3 region is important in tTreg and
pTreg differentiation and helps control the expression of Foxp3. It contains a binding site for cRel, a NFkB family member, which after binding promotes the transcription of Foxp3 by
forming a Foxp3-speicfic enhanceosome79,80.
More recently, a new site, CNS0, was discovered 8.5kb upstream of the transcription start
site (TSS)81. It was identified to contain the binding sites for Satb1, a global genome organizer.
Satb1 works to induce transcriptional and epigenetic regulation through the formation of novel
nuclear architecture82. While this area is still being studied, it is hypothesized that the binding of
Satb1 to the CNS0 region may play an essential role in commitment to the Treg lineage. While
the structure has been well studied, and the importance of Foxp3 in Tregs is apparent, work done
in my thesis invokes a challenge on this current knowledge. With Foxp3 appearing in neonatal
intestines immediately after birth, it seems that it may play a regulatory role in the developing
immune system within gd T cells, a topic that has not yet been addressed.

gd T Cells

Along with Tregs, gd T cells appear to also be important in mucosal sites, such as in the
intestines. Our current knowledge, however, on their specific mechanisms and functions is
lacking. gd T cells were first discovered in the mid-1980’s83-85, after the accidental discovery of a
third TCR chain in 1984, the g chain.86. gd T cells are found highly concentrated in mucosal sites,
which is the opposite of ab T cells, which are found mainly in secondary lymphoid organs. Of
these mucosal sites, gd’s have been identified in the epidermis87, in the lung, tongue, and
uterus22, as well as in the intestinal epithelium88,89. Their location in the body has been shown to
dictate which Vg/Vd chains of the TCR are present within each subset18,19. Along with a diverse
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TCR, gd T cells express CD3 on their surface. What makes gd T cells unique is their ability to
recognize molecules in both the classical MHC molecule-type way, as well as independently90-95.
gd T cells are among the first T cells to develop within the thymus of mice, appearing as
thymocytes around embryonic day (ED) 14.596. At this point in development, the frequency of gd
T cells is much higher than ab T cells, the opposite of which is true in a mature immune system.
The function, and potential importance of the increased gd’s is a gap in knowledge that needs to
be further explored. Due to fetal murine studies, we do know that the frequency of gd thymocytes
peaks around ED16.5, followed by a gradual decrease throughout development and into the 1st
week post-birth, where the amount of gd’s is about 0.3-0.5%, similar to adult levels96. The reason
for this sudden decrease remains to be found, however. gd’s are first detected in humans around
gestational week 6-9, where they have been found in the liver and in the developing gut97.
The cytokines produced by gd T cells appears to be variable and dependent on their
localization within the body. Most of the work regarding the cytokine profile of gd’s has been
completed utilizing clones, due to the limited amounts of gd cells in the body. To assess the
cytokine production post-activation, a PMA/ionomycin stimulation is commonly used. From this
type of work, it has been found that gd T cells in the epidermis of humans will produce IFN-g
and TNF 24 hours post-stimulation98. gd’s from murine lamina propria lymphocytes (LPL),
which are found in the intestines, produce IL-10 and IL-17 after PMA/ionomycin stimulation99.
Clones from murine spleens show high IFN-g and TNF expression100, while gd’s from
intraepithelial lymphocytes (IEL) express IL-10101. Overall, gd T cells are able to produce
cytokines of both a Th1 phenotype, like IFN-g, as well as of a Th2 phenotype, like IL-4, IL-5,
and IL-10102-104. The multifunctionality of these cells leaves the question of whether or not there
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are different functional subsets of gd T cells, which our single cell RNA sequencing data aims to
address.
gd T cells in the Gut

A majority of gd T cells in the gut express the CD8aa homodimer on their surface
alongside the TCRgd105. A gap in knowledge arises regarding the development of IEL gd’s, as
there has been evidence that supports their development both within the thymus as well as
thymus independent. It has been proposed that gd IEL’s are of fetal origin, as studies have shown
that transferring cells from the fetal (ED 15-16) liver, generates gd T cells in the intraepithelial
layer106. Of interest, studies have shown that the Vg7 chain is detected in the thymus around
ED13, while it is seen even earlier, at ED11, in the fetal gut and liver of mice23. These data is
showing that gd precursors appear to be present in the gut prior to the thymus. Other studies have
been conducted that support the idea that gd IELs arise independent of the thymus. In one,
athymic mice still had gd T cells present in the intraepithelial layer, just with decreased levels106.
Not only is the development of gd IEL’s unclear, but their function is not fully
understood. Many studies use TCRd-/- mice, which have no gd T cells, in order to observe any
functional changes that may occur without gd’s. In one of these studies, it was found that in the
TCRd-/- mice there was a reduction in the proliferation of epithelial cells in both the small
intestine and in the colon107, confirming the important role that gd IELs play in the maintenance
of homeostasis within the gut. Along with the decreased proliferation in the gut, TCRd-/- mice are
found to have increased gut permeability as the tight junctional complexes in the intestines are
decreased108. The increased intestinal permeability correlates with an observed increased
susceptibility to the development of spontaneous colitis in older mice109. Interestingly though,
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the transfer of gd IEL ameliorated the colitis, with a decrease in IFN-g and an increase in TGF-b
production109. It has also been found that there is a correlation between mice that lack gd T cells
and increased IFN-g production in the IELs of inflammatory bowel disease (IBD) mouse
models110.
There are multiple disease models that are used to understand the function of gd T cells in
the intestines, one of the most popular being the dextran sulfate sodium (DSS)-induced colitis
model system. In DSS-treated mice, large amounts of gd T cells were observed at sites of
epithelial damage and were found to express keratinocyte growth factor (KGF), an intestinal
epithelial cell mitogen111. This observation led to the idea that gd’s may be important in
upholding the integrity of intestinal epithelial sites that become damaged. Patients with celiac
disease have also provided potential insight into the role of gd T cells. Those that were on a
gluten free diet and were not experiencing any symptoms of active celiac disease, were found to
have an increased frequency of CD8+ gd IELs that expressed NKG2A, an inhibitory NK receptor
as well as TGF-b112. These data suggest the potential for gd IELs to function in a regulatory role
in the intestines of celiac patients.
gd T cells & Tolerance

One of the first studies that identified a potential role of gd T cells in tolerance induction
looked at OVA exposure in respiratory mucosa113,114. It was shown that upon exposure, splenic
CD8+ gd T cells became activated, and suppressed the OVA-specific IgE antibody response.
Along this line, it was also seen that the depletion of gd’s in vivo and in vitro led to the
production of anti-OVA antibodies as well as proliferation of OVA-specific T cells115.
Other studies using a NOD mouse model of spontaneous type I diabetes showed that
CD8aa+ TCRgd+ IELs are required for self-tolerance. In this model, the transfer of CD8aa+

12
TCRgd+ IELs into 3-day old NOD mice that had undergone a recent thymectomy, prevented the
development of diabetes116. Along with this, it was shown that even if there was an induction of
Tregs through oral insulin to euthymic mice, CD8aa+ TCRgd+ IELs were still required for
diabetes to be prevented116.
Immune Tolerance
Tolerance is extremely important in maintaining a homeostatic environment within the
body. It is defined by mechanisms that impair the immune response to self-antigens, while still
providing an appropriate and protective response against foreign antigens117. Immunological
tolerance was first introduced in 1945 by Ray Owen who conducted studies in cattle. He
observed that dizygotic twin cattle shared red blood cells (RBCs), noting two distinct phenotypes
of RBCs, that persisted into adulthood118. The absence of an immune response to dizygotic red
blood cells led to the proposal that foreign cells acquired before birth generated immunological
tolerance later in life to those same cells. Along with the tolerance to each other’s RBCs, most of
the cattle were also tolerant to a skin allograft from their dizygotic twin119,120.
Billingham, Brent, and Medawar were another group that was instrumental in progressing
the knowledge on tolerance. In 1953, they demonstrated that the injection of allogeneic tissue
into mice while in utero led to the establishment of tolerance to the tissue later in life, when a
skin allograft from the same strain was introduced121. However, mice that were injected after
birth failed to acquire the same immunological tolerance121, leading to the idea that there is a
small window in which tolerance can be established during which alloantigens are exposed.
Types of Tolerance
There are two types of tolerance, central and peripheral tolerance. Central tolerance is the
first line of defense against self-reactive T and B cells, taking place in the thymus and bone

13
marrow where lymphocytes are first generated. If a lymphocyte is deemed to have strong
autoreactivity, it will undergo either clonal deletion35 or clonal diversion122. In clonal diversion,
T cells that express a self-reactive TCR will differentiate into tTregs, which leave the thymus and
enter the periphery where they function to suppress any autoreactive T cells that may have
escaped negative selection122.
Peripheral tolerance occurs in the periphery, when lymphocytes that are autoreactive have
escaped the previously described protections in the thymus. When this occurs, there are a few
mechanisms in place to prevent further issues. One of these includes inducing a state of anergy
within the autoreactive cells, in which cells are alive and functional, but do not respond to
antigen stimulation. This concept was first introduced by Nossal in the 1980’s, after the
discovery of mature, autoreactive B cells within circulation that had no response to antigen
stimulation123. This phenomenon was also seen in T cells that remained unresponsive to antigen
stimulation when activated in the absence of CD28, a costimulatory molecule, or CTLA-4, a
coinhibitory molecule124.
Antigen presenting cells (APCs) also play an important role in the maintenance of
peripheral tolerance. Dendritic cells (DC) specifically contain the ability to deliver coinhibitory
signals, or an inadequate amount of costimulatory signals, which promote a tolerogenic response
in T cells, limiting their activation and subsequent proliferation125. However there does not exist
a singular subset of DCs that assists in peripheral tolerance, but instead it has been theorized that
this function may be induced when the DCs are found in the presence of certain antiinflammatory cytokines126.
Another type of regulatory t cell, termed type 1 Tregs or Tr1, has been identified as
playing a role in peripheral tolerance127. These Tr1 cells, unlike conventional Tregs, do not
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express Foxp3 and have low levels of CD25128. Studies done in IPEX patients, a disease caused
by a Foxp3 mutation, showed that Tr1 cells with suppressive capabilities can be isolated from
peripheral blood, confirming that Foxp3 is not required for their induction or function129. While
tolerance is quite well understood, the tolerogenic state of neonates leaves some room for
questions. With our work showing Foxp3 expression in neonatal IEL gd’s, the question of
whether these cells are taking on a tolerogenic role arises.
Perinatal Immunity
Looking further at this time in development, known as the perinatal period, it consists of
both fetal and neonatal stages of life. In humans, this period begins at gestational week 22 and
ends 1 week after birth130, while in mice it begins at embryonic day 9 and lasts 7 days after
birth131. It was initially thought that the neonatal immune system had an impaired response when
compared to a mature immune system, however the more work that has been done in this field
has shown that the neonatal immune system is actually very active but has a higher propensity
towards existing in a state of tolerance, as is needed for proper development132,133. For a fetus to
exist in utero, it must adopt a highly tolerogenic state as it exists in a semi-allogeneic
environment134. While not fully understood, this state appears to be reached by the generation of
Tregs, which help to block the fetal immune response during development. After birth, newborns
are bombarded with a variety of commensal microbes, pathogens, and environmental antigens,
which they must quickly learn how to distinguish between135. This is essential to prevent an
overactive immune response and excessive inflammation that could be detrimental to the
neonate’s health.
The tolerogenic state that newborns find themselves in also renders them more
susceptible to pathogens, which can be fatal. Most newborn deaths are caused by diseases that
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are preventable upon vaccination, however since the neonatal immune system is highly tolerant,
the efficacy of vaccines is significantly reduced136,137. Maternal antibodies have been observed to
transfer to the fetus trans-placentally, offering the susceptible newborn some protection from
pathogens for the first 4-6 months of life138.
Many studies have investigated the impact growing up in a farming community plays on
tolerance and immune responses later in life. From these studies, it has been observed that
tolerance likely develops in utero, since umbilical cord blood (UCB) from fetuses with maternal
exposure to farming have been found to have increased Tregs as well as an increase in
suppressive capabilities139,140. Not only does it appear that immunosuppressive functions are
increased, but there also is a decrease in IL-5 and IL-13, both of which are associated with
allergic reaction140. Exposure during childhood to a farming environment has also been
correlated with increased protection against allergic diseases later in life141,142.
In neonatal murine models, there is an increased amount of IL-4 production in T cells in
response to TCR stimulation when compared to adult T cells143. The Th2-like response in
neonates declines within 5 days after birth and is then comparable to adult levels144. In human
UCB, naïve T cells show more of a Th1 response, with a decrease in IFN-g when compared to
adult naïve T cells in normal conditions145. Upon TCR stimulation, UCB secretes increased IL10, an anti-inflammatory cytokine, whereas adult T cells do not146.
Both human and mice neonates have been shown to have a decrease in CD8+ T cell
responses to infection. Neonatal mice appear to have a deficient CD8+ T cell response against
influenza, herpes simplex virus (HSV), and respiratory syncytial virus (RSV)147-149, similar to
human infants, who also show a severely decreased response of CD8+ T cells to RSV, HSV and
influenza150. Neonatal CD8+ T cells that are present appear to have a decrease in granzyme B,
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IFN-g, and IL-2 than in adult CD8+ T cells151. Naïve CD4+ T cells from UCB152 and from fetal
lymphoid organs153 have a much higher frequency than adult naïve cells to differentiate into
Foxp3+ Tregs after antigen receptor stimulation.
Helios
When searching for the master regulator of T cell development, the transcription factor
Ikaros, encoded by the Ikzf1 gene, was first cloned154. 4 other members of the Ikaros family were
identified shortly after, including Helios (Ikzf2), Aiolos (Ikzf3), Eos (Ikzf4), and Pegasus (Ikzf5).
Ikaros are zinc-finger transcription factors that are characterized by 2 conserved zinc-finger
motifs155. The first motif is the amino terminal (N-terminal), which contains DNA binding
domains, while the second motif is the carboxyl terminal (C-terminal) which contains domains
for interactions with the other Ikaros proteins, or transcriptional regulators156,157.
Identified initially as a dimerization partner of Ikaros, Helios was first cloned in 1998158,
when it was found at centromeric heterochromatin regions within the T cell nucleus in complex
with Ikaros. Helios was noted to be of T cell lineage, and was found in all fetal hematopoietic
sites, earliest lymphoid progenitors, and in adult HSCs158. My thesis attempts to elucidate further
understanding of where exactly Helios is arising from. Our current knowledge points towards
HSCs as its source, which is why we chose to explore this connection further.
The group that first identified Helios performed a northern blot analysis in order to track
its expression in the developing fetus. What they found was that Helios was first detected in the
blood islands of the yolk sac at embryonic day (ED) 8. At ED11, Helios was expressed in the
fetal liver, followed by detection of it within the epithelial lining of the gut at ED13. On ED16,
Helios was found near the thymus, trachea, and epithelial linings of the esophagus. At ED17, the
fetal liver no longer expresses it, but Helios is instead found in multiple epithelial tissues,
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including the lungs, skin, mouth, and salivary glands. Helios mRNA was detected in both CD4CD8- thymocytes as well as CD4+ CD8+ thymocytes but declines as these subsets transition into
single positive thymocytes158-160.
Helios was thought of as a tumor suppressor during initial analysis in tumor cell lines
since human T cell leukemia, human T cell lymphoma, and T cell acute lymphoblastic leukemia
cell lines all overexpressed a short isoform of Helios that lacked 3 out of the 4 N-terminal
domains161,162. Upon further analysis of this Helios isoform, it was found that any association
with Ikaros, Aiolos, or Helios of full length, the DNA-binding activity was inhibited163. Helios-/mice have significant perinatal fatality, so studies with total knockout mice are unable to be
done182.
While the mechanisms behind Helios are not fully understood, many studies have
implicated Helios in the function of Tregs. It has been found that Helios+ Tregs appear to have an
increase in suppressive capabilities when compared to Helios- Tregs164-167. Supporting this, Tregs
that had impaired expression of Helios expressed less Foxp3 and instead had higher amounts of
IFN-g, TNF, and IL-17168. These Helios-deficient Tregs also failed to improve inflammatory
bowel disease in RAG-/- mice after being transferred168. Helios was found to function as an IL-2
regulator, with the ability to suppress the IL-2 gene transcription in Tregs with the help of
Foxp3169. The potential role of Helios in Tregs is strengthened by our observation that fetal and
neonatal mice have high amounts of Helios in the periphery, which diminishes shortly after birth
but remains high in the intestines, a site that needs to have increased tolerance.
CD8ab+ TCRgd+ T Cells
Our work done in fetal and neonatal mice led to the identification of a new subset of cells
within their intestines that we observed to be present in young mice but not in adult intestines.
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These cells are TCRgd+ and express a CD8ab heterodimer. There has been very limited research
done on CD8ab+ TCRgd+ T cells in humans or in mice. They were first identified in the early
2000’s in the IEL of athymic mice170. These CD8ab+ TCRgd+ T cells were observed to have
cytolytic activity and were IFN-g producing, but researchers noted that their location varied
within mice and appeared to potentially be influenced by microenvironment stimuli. Other
potential functions of these cells have not yet been addressed, leading us to further study them.
More recently, a paper came out in 2016 identifying CD8ab+ TCRgd+ T cells in IBD
patients171. They observed a negative correlation between the amount of these T cells and the
disease severity, noting a significant decrease in CD8ab+ TCRgd+ T cells in the mucosa of
patients with active disease when compared to healthy patients. Treatment with anti-TNF
appeared to increase the levels of these cells, bringing them close to what was observed in
healthy persons. This paper presented a potential role of these CD8ab+ TCRgd+ T cells in
maintaining gut homeostasis, and potential mucosal healing in IBD patients. While these studies
offer a glimpse into the potential function of CD8ab+ gd T cells, a large gap in knowledge is
present that needs to be addressed. Understanding their origin and function, may have important
implications for a possible role they may play in the developing immune system or in IBD
patients.
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CHAPTER TWO
MATERIALS AND METHODS
Umbilical Cord Blood
Total umbilical cord blood (UCB) was collected into blood collection bags containing a
citrate phosphate dextrose solution. UCB was donated from Loyola University Medical Center
donors. UCB was processed to obtain lymphocytes through density centrifugation using
Lymphopure density gradient medium (Biolegend, San Diego, CA) and centrifuged at 1500rpm
at 25C for 20 minutes with no brake. Red blood cells were lysed using RBC lysis buffer
(Biolegend, San Diego, CA). Donors were excluded if there was evidence of any active
malignancies, if any immunomodulatory medications were used, if they had uncontrolled hyper
or hypothyroidism, if they had an autoimmune disorder, or if there was the presence of an active
infection.
Flow Cytometry
In vitro cultured cells or ex vivo cells were stained. Both surface and intracellular
molecules were labeled with fluorophore-conjugated antibodies following standard staining
protocols. Cells were first stained with Zombie Aqua Fixable Viability dye (Livedead) for 10
minutes, then washed with FACS buffer [PBS, NaN3, 10% FCS, deionized water]. Trustain
(BioLegend, clone 93), which is used as an Fc-block, was added to cells for 10 minutes on ice in
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the dark (.5ul per 106 cells), followed by the addition of the all antibodies for 30 minutes. Cells
were then washed and fixed with True-Nuclear Transcription Factor Buffer Set (BioLegend)
overnight. To stain for intracellular proteins, the 10X Perm buffer (BioLegend)was diluted to 1X
and cells were washed twice before adding intracellular stain for 1 hour. Cells were then washed
and filtered using nylon mesh to remove any debris. Data was collected using the FACS
LSRFortessa or the FACS Canto II, both which are manufactured by BD Bioscienceses. Analysis
of data was done using FlowJo software.
Antibodies
For flow cytometry, the following antibodies were used: Zombie Aqua Fixable Viability
dye (Livedead), anti-mouse CD4, CD8a, CD8b, CD45, CD45.1, TCRgd, TCRb, Foxp3, IL-10,
IFN-g, SCA1, IL-2RB, CKIT, anti-human/mouse Helios, and anti-CD3.
Cell Marker

Color

Brand

Titration

Clone

anti-mouse CD4

FITC

Biolegend

1:200

GK1.5

anti-mouse CD8a

PE/Cy7

Biolegend

1:200

53-6.7

anti-mouse CD8b

APC

Biolegend

1:200

YTS156.7.7

anti-mouse CD45

APC/Cy7

Biolegend

1:50

30-F11

anti-mouse CD45.1

FITC

Biolegend

1:50

A20

anti-mouse TCRgd

Percpcy5.5 Biolegend

1:200

GL3

anti-mouse TCRb

BV711

Biolegend

1:200

H57-597

anti-mouse Foxp3

PE

Biolegend

1:50

150D

anti-mouse IL-10

APC

Biolegend

1:200

JES5-16E3

anti-mouse IFN-g

PE

Biolegend

1:200

XMG1.2
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anti-mouse IL-2Rb

APC/Cy7

Biolegend

1:200

TM-b1

anti-mouse CKIT

FITC

Biolegend

1:200

2B8

anti-human/mouse Helios

Pacblue

Biolegend

1:2

22F6

Biolegend

5ug/mL

145-2C11

Soluble anti-CD3

Mice
C57BL/6 mice (originally received from Jackson Laboratories), RAG2 knockout mice
and C57BL/6 CD45.1 mice were bred and maintained in house. Mice older than 10 days old
were euthanized using CO2 and cervical spine dislocation. Mice under 10 days old were
decapitated. Organs were isolated using sterile tools and immediately processed to obtain singlecell suspensions. To collect fetal samples, timed pregnancies were set up, using ED0.5 as the
next day.
Intraepithelial Lymphocytes (IEL) and Lamina Propria Lymphocytes (LPL) Isolation
The small intestine was carefully isolated from the mouse and separated from colon.
Yamamoto et al protocol was followed with minor modifications172. Payer’s patches, mesentery
lymph nodes, fecal matter and fat were removed from small intestine tissue. Tissues were then
cut longitudinally, then into 1cm pieces which was vortexed in PBS to remove any remaining
fecal waste. Tissues were then placed in 10% HBSS containing fetal calf serum, 10mM HEPES,
and 1mM Dithiotthreittol (DTT, Sigma Alrich) and was incubated in 37°C warm room, rocking
for 30 minutes. Tissues were vortexed and intraepithelial lymphocytes (IELs) were collected
through 100µm filter. The remaining tissues were then placed in 10% HBSS containing
0.1mg/ml DNAseI (Roche, Basel, Switzerland), 2mg/ml Collagenase D (Sigma Aldrich), and
0.17U/ml Dispase (Gibco, Thermo Fisher Scientific), and cut into smaller pieces using sterile
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scissors. This tissue was then placed in 37°C warm room for 30 minutes on a rocker. Lamina
propria lymphocytes (LPLs) were collected through a new 100µm filter, and enzymatic digestion
was stopped with 10% HBSS containing 5mM EDTA. Both IELs and LPLs were washed in 10%
HBSS and then resuspended in a 40% Percoll with RPMI solution. IELs used a 70% Percoll
solution for isolation, and LPLs used a 80% Percoll solution. Purified IEL/LPL were harvested
from cell interphase after centrifuging for 20 minutes at 600g with no brake.
Spleen Isolation
The spleen was isolated from mice and grinded using Frosted Microscope Slides in PBS.
Splenocytes were then washed, and 1ml of ACK Lysing Buffer (Thermo Fisher) was added to
cells for 1 minute. Then, the cells were washed with PBS and resuspended in 2% FCS RPMI
media.
Suppression Assay
The spleen from a C57BL/6 CD45.1 mouse was sterilely isolated and processed with
ACK Lysing Buffer (Thermo Fisher). Splenocytes were washed with PBS and resuspended in
RPMI media. Total T cells were isolated from non-T cells using the Miltenyi Biotec TCRgd+ T
Cell Isolation Kit and stained with Cell Trace Violet to track proliferation. The spleen from OTII Transgenic mice was sterilely isolated as well and was processed to obtain splenocytes.
TCRgd+ T Cell Isolation Kit was used to purify gd’s from splenocytes and were resuspending in
RPMI media. Equal amounts of CTV-labeled CD45.1 total T cells and non-T cells were mixed
together in a U-bottom 96-well plate. OT-II gd T cells were added in a dose-dependent manner
(100µl of cells at 3x106, 1x106, and 3x105 per mL). Certain conditions were stimulated with
5ug/mL anti-CD3 antibody (Clone: 145-2C11) and plate was placed in a 37°C incubator for 3
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days. Cells were then harvested and labeled with anti-mouse CD45.1, CD4, CD8a, and CD8b.
Samples were analyzed on FACS LSRFortessa.
Single-cell RNAseq
Intraepithelial lymphocytes (IEL) from the intestines and spleen of 2 C57BL/6 mice were
sterilely isolated and processed according to the protocol previously described. Cells were
diluted to 1-2 million cells in Cell Staining Buffer and stained with anti-CD45 (103154), antiCD3 (100312), anti-mouse TotalSeqTM-A CD4, TotalSeqTM-A CD8a, TotalSeqTM-A TCRb
chain, TotalSeqTM -A TCRgd, and TotalSeqTM-A CD8b antibodies following the TotalSeqTM
Dual Index Protocol. TotalSeqTM antibodies are conjugated with oligonucleotides which contain
a barcode sequence for further single cell analysis. CD45+CD3+ cells were sorted into DMEM +
10% FCS. Sorted cells were used following 10X Genomics single-cell RNAseq protocol.
Samples were sent to Northwestern University for analysis. Pathway analysis was done using
Metascape, which converts gene lists into M. musculus gene IDs using GO biological processes,
KEGG Pathway, Reactome Gene Sets, CORUM, TRRUST, PaGenBase, and WikiPathways.
Terms with a p-value < 0.01, a minimum count of 3, and an enrichment factor > 1.5 were
grouped based on membership similarities.
Depletion Assay
The spleen from a C57BL/6 CD45.1 male mouse was sterilely isolated and processed.
Cells were sorted for the following conditions: Total T cells, Total T cells depleted of
TCRgd+ CD8ab+ T cells, T cells depleted of Tregs (CD4+CD25+), and T cells depleted of both
TCRgd+ CD8ab+ T cells and Tregs. Equal amounts of cells from each condition was injected
retro-orbitally into RAG2 knockout mice that had been irradiated 24 hours prior to injections.
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Mouse weights were recorded on the day of injections as their baseline weight and every 3 days
afterwards to monitor for weight loss.
Adult and Fetal HSC Transfer
Adult bone marrow and fetal liver (ED17.5) hematopoietic stem cells (HSCs) were
isolated from CD45.1 mice using the EasySep Mouse Hematopoietic Progenitor Cell Isolation
Kit. CD45.1 HSCs were injected retro-orbitally into RAG2KO mice that had been irradiated 24
hours before at 2.5 Gy. 6 weeks later, peripheral blood from RAG2KO mice was collected and
stained with anti-mouse CD45.1 and CD45.2 to check for HSC reconstitution. Once confirmed,
mice were sacrificed and organs were harvested for analysis via flow cytometry.

CHAPTER THREE
MOLECULAR AND CELLULAR CHARACTERIZATION OF γδ IELS AND LPLS
Splenic and Intestinal Barcoded scRNAseq Analysis for Potential γδ T Cell Function
While γδ T cells were discovered nearly 40 years ago83-85, they are still a subset of
immune cells that have a lot of unanswered questions surrounding them. Part of the reason this is
the case may be due to their low numbers found in adult models, especially when compared to
their counterpart ab T cells, which make up a much larger percentage of T cells. Due to this
constraint, and the abundance of knowledge it would hopefully provide us with, we decided to
pursue further knowledge regarding γδ T cells by performing a single cell RNA sequencing
experiment utilizing a barcoded antibody-based approach. This was chosen with the intent on
functionally characterizing specific clusters of cells based on their gene expression.
To prepare samples for sequencing, we first isolated lymphocytes from the gut and spleen
of 2 adult C57Bl/6 mice and prepared cell suspensions for sorting. Cells were stained with CD45
and CD3 to separate out the lymphocyte population, as well as TotalSeqTM-A antibodies for TCR
and coreceptor identification after analysis. CD45+CD3+ live cells were sorted for and the 10X
Genomics single-cell RNAseq protocol was initiated immediately after to ensure cell viability.
Upon successful sample preparation, the cells were transferred to the NuSeq Core Facility at
Northwestern University for sequencing and analysis.
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The initial findings from this experiment, provided by the team at Northwestern
University, gave us insight into how the cells were clustered from both the spleen and gut
(Figure 1b) and showed distinct clusters of cells among both samples, with the gut lymphocytes
characterized as group 0, group 3, and group 8 (Figure 1a). Furthermore, the results from the
barcoded antibody approach allowed for a distinction between TCRab and TCRγδ cells within
the clusters. Shown as violin plots, we see that there are 3 distinct populations of γδ T cells,
groups 0, 3, and 8, (Figure 2a) which when compared to the UMAP data are all cells from the
gut. This is further confirmed with analysis of the TCRb violin plot which shows that clusters 0,
3 and 8 do not express the TCRb chain (Figure 2b). We were able to characterize these groups of
cells further with the identification of CD4, CD8a, and CD8b coreceptor expression within the
γδ clusters, which each showed low CD4 and CD8b expression (Figure 3a,c). We instead saw
that all 3 of the γδ clusters, group 0, 3 and 8, expressed CD8a (Figure 3b).
With this initial finding of 3 groups of γδ T cells that express CD8a, we wanted to
determine what was differentiating each from one another. The genes that were found to be
differentially expressed within each group from our initial data showed a potential for unique
functions between the clusters. To further explore this, we decided to run a pathway analysis to
identify possible functions for each group. This was done using Metascape173 which converts
gene inputs into M. musculus gene IDs using multiple ontology sources and clusters similar
genes together.
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Figure 1. Single Cell RNAseq UMAP Clustering. Analysis via single cell
RNAseq of 2 gut and 2 spleen samples from C57Bl/6 mice prepared using 10X
Genomics protocol. (a) Clustering of individual cell subsets, identified by colors
on right hand side. (b) Clustering of total gut and spleen cells.
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The first group of γδ’s that was analyzed was cluster 0. Using the Metascape software,
we produced an analysis of its enriched ontology clusters. These were hierarchically clustered by
the most significant gene populations and the functional terms that best describe each group was
mapped out (Figure 4a). It appears that this group of gut γδ T cells have an increased propensity
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towards regulating the defense response within the gut. This could potentially mean that this
group of cells is performing a function like that of Tregs, in which it may be limiting the immune
response in the intestines. As a mucosal site that is constantly bombarded with environmental
antigens, these cells may be playing a crucial role in deciphering when an immune response is
necessary. To visualize the relationship between the enriched terms, a network plot was
generated using Metascape software. From this network, the cells within this cluster that appear
to regulate the defense response in the gut, are also closely related to those that regulate the
immune effector process (Figure 4b).
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Following the same procedure, the genes expressed in cluster 3, another subset of γδ’s
that express CD8a alongside TCRγδ, were analyzed. From the enriched ontology clusters, it
appears that this group of cells may be important in the adaptive immune response, as well as in
regulating leukocyte activation (Figure 5a). This subset of γδ T cells appears to be potentially
acting on pathogens and promoting activation of the immune system when necessary, opposite of
the first group of γδ’s. With the help of a network plot to visualize any relationship between
these two functions, it does appear that the genes within both ontology groups are related (Figure
5b). As this kind of response is typically carried out by CD4+ T cells, it is important to note again
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that this cluster of cells, along with the other two, do not appear to be expressing CD4 (Figure
3a).

Lastly, cluster 8 was analyzed to gain insight into their potential role in the gut. The
enriched ontology from the genes expressed by this group of cells shows that they may be
playing a similar role to that of the γδ cells in cluster 3. These cells are enriched for genes that
are important for cell activation, as well as genes that help to increase the immune defense
response when needed, noted as positive regulation (Figure 6a). Along with these functions, γδ’s
in cluster 8 appear to interact with neutrophils, their activation and movement towards an
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indicated site. The network plot for this group does not appear to provide any valuable
contribution towards the functional relationships of these cells (Figure 6b).
While each group of γδ T cells in the gut appear to be similar, with each expressing
CD8a alongside TCRγδ, the subset of cells typically seen in the intestines, this data provides
evidence for our hypothesis that there may be different subtypes of γδ T cells working together
within the gut, and potentially other mucosal sites, to maintain a state of homeostasis. One group
may be involved in regulating the defense response, so that the gut is not constantly inflamed,
while another group is prepared for when the immune response needs to be activated to protect
the host, and lastly a third group appears to also be activating cells but seems to be geared more
towards recruitment of other immune cells, such as neutrophils, to aid in the defense. The
differential genes within each group were tested for protein expression to confirm their presence
within the gut, however at this time we have not found any significant gene expression within the
gut.
Discovery of a New Foxp3+ Subset of γδ T Cells
The perinatal immune system, which involves both fetal and neonatal stages130,131 of life,
is a highly tolerogenic state that the developing fetus and newborn must remain in to survive.
After birth, the neonate is bombarded with an array of new antigens, some commensals and some
pathogenic, which they must quickly learn how to distinguish138. The mechanism behind this
aspect of development is what we decided to seek out, specifically in relation to the gut
environment, where exposure to new environmental antigens is abundant.
Initially, we sought to compare the intestinal phenotypes between three different ages of
mice: fetal mice (embryonic day 17.5/18.5), neonatal mice (5 days old), and adult mice (6-8
weeks old). We isolated the small intestine and spleens from each age group, pooling together
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the whole fetal guts to obtain adequate cell numbers. After separating intraepithelial lymphocytes
(IEL) from lamina propria lymphocytes (LPL), cells were stained with antibodies and analyzed
using flow cytometry. We discovered that a subset of γδ T cells that expressed the heterodimer
CD8ab within the fetal and neonatal intestines. This subset was absent in the adult intestines
(Figure 7a-c). Exploring this subset further, we looked at the intracellular expression of Helios
and Foxp3. We found that within the neonatal intestines, there was a small portion of CD8ab+
TCRγδ+ cells that expressed Foxp3 (Figure 8). Foxp3 is an important transcription factor for
regulatory T cells (Tregs), acting as a key player in their development and as a master regulator
in their function72,73,74. Due to this knowledge, we hypothesized that these intestinal Foxp3+
CD8ab+ TCRγδ+ T cells in neonates are acting in a manner like that of Tregs, providing
immunosuppressive effects immediately after birth. Since the cells are present in fetal intestines
but absent of Foxp3, it is possible that they may play a role in development but once exposed to
the outside environment transition into a regulatory role to help maintain homeostasis after birth.
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Figure 7. Fetal, Neonatal, and Adult IEL CD8 Expression. Intraepithelial
lymphocytes isolated from (a) fetal (ED 17.5/18.5), (b) neonatal (5 day old), and (c)
adult (4-6 weeks) C57Bl/6 mice were processed and stained with antibodies for
analysis via flow cytometry. Gating in all panels shows CD8a and CD8b expression
in live cells previously gated for CD45+ CD3+ TCRgd+ cells. N=6 (adult), N=3 (pooled
neonate litter), N=3 (pooled fetal litter)

Figure 8. Foxp3 and Helios Expression in TCRgd+ CD8ab+ Fetal and Neonatal IELs.
Intraepithelial lymphocytes isolated from (a) fetal (ED 17.5/18.5) and (b) neonatal (5 day
old) C57Bl/6 mice were processed and stained with antibodies for analysis via flow
cytometry. Gating in all panels shows Foxp3 and Helios expression in live cells previously
gated for CD45+ CD3+ TCRgd+ CD8ab+ cells. N=3 (pooled fetal liver), N=3 (pooled
neonatal liver)
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Figure 9. Foxp3 and Helios Expression in OT-II Intestines. Intraepithelial lymphocytes
(IEL) and lamina propria lymphocytes (LPL) isolated from (a) adult OT-II transgenic mice
and (b) adult C57Bl/6 mice were processed and stained with antibodies for analysis via
flow cytometry. Gating in all panels shows Foxp3 and Helios expression in each subset of
live cells previously gated for CD45+ CD3+ TCRgd+ cells. N=2 (OT-II), N=3 (B6)
Foxp3+ γδ T Cells Suppress T Cell Proliferation
Since Foxp3+ CD8ab+ TCRγδ+ T cells appeared to be a small percentage of cells, we
decided to pursue a potential function for Foxp3+ γδ T cells instead. γδ T cells have not been
reported to have Foxp3 expression except when induced in vitro with TGF-b and IL-15174,175.
We hypothesized that since the γδ T cells express Foxp3, they would have immunosuppressive
functions like Tregs. To test this, we utilized OT-II transgenic mice which we had previously
found to express high levels of Foxp3 in TCRγδ+ IELs and LPLs (Figure 9). If our hypothesis is
correct, we expect to see a decrease in proliferation of T cells due to the immunosuppressive
effects that the γδ T cells would produce.
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Figure 10. OT-II Splenic gd T Cells Suppress T Cell Proliferation. CD45.1+ C57Bl/6 T
cells were separated from APCs by magnetic separation. gd T cells were sterilely isolated from
OT-II spleens and added to wells containing combined T cells and APCs at different ratios
(1:1, 1:3, 1:10). Cells were stimulated with anti-CD3 in a 96-well plate and incubated at 37°C
for 3 days. CTV expression is shown on the x-axis, and cell number is shown on the y-axis.
Both CD4+ and CD8+ T cells are shown above. Stimulated samples represent CD45.1 T cells
and APCs that were stimulated with anti-CD3 but did not receive any OT-II gd’s. Gating
shows percentage of cells divided in each condition. N=1
Hematopoietic stem cells (HSCs) isolated from fetal (ED17.5/18.5) liver (fetal HSC transfer)
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followed by the addition of 3 differing amounts of OT-II γδ T cells (1:1, 1:3, 1:10) from the
spleen. We decided to test if addition of γδ T cells in these culture suppress T cell proliferation.
Cells were then stimulated with anti-CD3 antibodies and incubated at 37°C for 3 days. Once
adequate proliferation was observed, cells were harvested and stained for flow cytometry
analysis.
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After stimulation with anti-CD3 antibodies for 3 days, we observed that the CD45.1
CTV-labeled T cells and non-labeled APC’s with the highest concentration of spleen γδ T cells
(1:1) had a substantial decrease in proliferation among T cells (Figure 10). The suppression of T
cells is seen in both CD4+ and CD8+ cells. In CD4+ T cells, a 1:1 ratio of OT-II γδ T cells
decreases the proliferation percentage from 44.9% to 3.78%. An even larger suppressive effect is
seen in CD8+ T cells, in which proliferation decreases from 83% to 5.66%. When less γδ T cells
from the OT-II spleen were added to the splenocytes there was a decreased effect on suppressing
proliferation of T cells, so it appears that the amount of suppression is dependent on the number
of γδ T cells added. Similar data was observed in the γδ T cells isolated from OT-II intestines.
Together these data support our hypothesis that Foxp3+ γδ T cells have suppressive effects.

CHAPTER FOUR
DEVELOPMENTAL CONTROL OF HELIOS EXPRESSION BY GUT-ASSOCIATED T
CELLS
Helios Expression by Fetal, Neonatal, and Adult IELs

Figure 11. Helios and Foxp3 Expression in Umbilical Cord Blood. Total UCB was
collected into blood collection bags containing a citrate phosphate dextrose solution.
Lymphocytes were obtained via density centrifugation with Lymphopure medium. Cells
were processed and stained with antibodies for analysis via flow cytometry. Gating in all
panels shows Foxp3 and Helios expression in CD8+ and CD4+ subsets of live cells
previously gated for CD45+ CD3+ cells. N=3

With the knowledge that the perinatal immune system takes on a highly tolerogenic state
to allow for proper development, our lab previously studied potential transcription factors that
may contribute to this state. From this, we discovered that Helios, which is important in the
maintenance of Treg stability and suppression176-179 was highly expressed in umbilical cord
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blood (UCB) (Figure 11). Along with its appearance in human perinatal cells, we also observed
high levels of Helios in murine intestinal γδ T cells. Due to these findings, we hypothesized that
we would see higher Helios expression in fetal and neonatal intestines, due to their propensity to
induce a tolerogenic state.

Figure 12. Helios and Foxp3 Expression in Fetal, Neonatal, and Adult IELs and LPLs.
Intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) were isolated from
the small intestine of (a) fetal (ED17.5/18.5), (b) neonatal (5 day old), and (c) adult C57Bl/6
mice. Cells were processed and stained with antibodies for analysis via flow cytometry.
Gating in all panels shows Foxp3 and Helios expression in the CD8aa+ subset of live cells
previously gated for CD45+ CD3+ TCRgd+ cells. N=3 (pooled fetal liver), N=3 (pooled
neonatal liver)
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Figure 13. Helios and Foxp3 Expression in Fetal, Neonatal, and Adult LPLs. Lamina
propria lymphocytes (LPLs) were isolated from the small intestine of (a) fetal (ED17.5/18.5),
(b) neonatal (5 day old), and (c) adult C57Bl/6 mice. Cells were processed and stained with
antibodies for analysis via flow cytometry. Gating in all panels shows Foxp3 and Helios
expression in each subset of live cells previously gated for CD45+ CD3+ TCRgd+ cells. N=3
(pooled fetal liver), N=3 (pooled neonatal liver)
To test this, we analyzed the intestines and spleen from fetal (embryonic day 17.5/18.5),
neonatal (5-day old), and adult B6 mice for Helios expression. Across all ages, Helios expression
was most prominent in CD8aa+ γδ T cells, which are the most abundant subset we see in the
intestines. We observed the high Helios expression in CD8aa+ γδ T cells from both fetal IELs
and LPLs (Figure 12, 13). High Helios expression was also seen in intestinal CD8aa+ γδ T cells
of neonates, but expression at this age appears more similar to adult Helios expression than fetal
(Figure 12, 13).
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Figure 14. Helios and Foxp3 Expression in Fetal, Neonatal, and Adult Spleen.
Splenocytes were isolated from the spleen of (a) fetal (ED17.5/18.5), (b) neonatal (5 day old),
and (c) adult C57Bl/6 mice. Cells were processed and stained with antibodies for analysis via
flow cytometry. Gating in all panels shows Foxp3 and Helios expression in subsets of live
cells previously gated for CD45+ CD3+ TCRgd+ cells. N=3 (pooled fetal liver), N=3 (pooled
neonatal liver)
While it appeared that Helios was highly expressed in intestinal γδ T cells across the 3
different age groups, we wanted to determine if this was specific only to the gut or if it was seen
in the periphery. To do this, we analyzed Helios expression from fetal, neonatal, and adult
spleens. We saw that Helios expression was decreased in CD8ab+ γδ T cells from each age
group, but that fetal spleens had the highest expression overall (~93.5%) in CD8- CD4- γδ T cells
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(Figure 14). While this subset still showed high Helios expression, it appeared that overall,
Helios was decreased among splenic γδ T cells.
Overall, these data show that Helios is playing an important role in fetal development,
especially within the intestines. Since the developing immune system lacks Tregs during the first
few days after birth, it is possible that these Helios+ γδ T cells are functioning to promote and
maintain perinatal tolerance. With the decrease in expression in the spleens across all ages, it
appears that peripheral T cells lose Helios expression right after birth. This contributes to the
notion that Helios has an important role in the intestinal environment specifically.
Transferred Fetal and Adult HSC gives rise to Helios-expressing γδ T cells in RAG2KO
Mice
The ability for Helios to potentially contain self-renewing capabilities was observed in
acute myeloid leukemia, where IKZF2 was found to play an important role in driving selfrenewal of leukemia stem cells and inhibiting myeloid differentiation180. Perinatal-derived γδ T
cells, like those found at mucosal sites, have the ability to self-renew locally instead of being
replaced by circulating precursors181. Helios is found in fetal hematopoietic sites and in adult
HSCs158, however its origin is still unknown. To address this gap in knowledge, we decided to
pursue where Helios is originating from. We hypothesized that Helios+ γδ T cells in the gut were
coming exclusively from hematopoietic stem cells (HSCs) and that this expression was
maintained by self-renewing properties. Since peripheral T cells appear to lose Helios shortly
after birth, we proposed the concept that the T cells in the periphery lack this self-renewing
property while intestinal γδ T cells continue to self-renew.
To test this, we set up an experiment using HSCs isolated from adult bone marrow and
fetal liver of C57Bl/6 CD45.1 mice. Once processed, these cells were retro-orbitally injected into
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previously irradiated RAG2KO mice, which lack T and B cells. Approximately 6-8 weeks later,
we checked for adequate reconstitution of CD45.1+ cells in the periphery prior to sacrifice. Upon
successful reconstitution, the gut and spleen from these mice were analyzed for Helios
expression. If our hypothesis was correct, then we would expect to see Helios expression only in
the mice that had received HSCs from the fetal liver, and not those that had received the adult
bone marrow HSCs.

Figure 15. Helios Expression in TCRgd+ IEL & LPL Cells. Hematopoietic stem cells (HSCs)
isolated from either adult bone marrow (adult HSC transfer) or fetal (ED17.5/18.5) liver (fetal HSC
transfer) were retro-orbitally injected into RAG2 deficient mice. (a) intraepithelial lymphocytes
(IEL) and (b) lamina propria lymphocytes (LPL) were both analyzed. Confirmation of
reconstitution was done 6-8 weeks later through flow cytometry analysis confirming the presence of
CD45.1+ cells. Mice were then sacrificed, and their organs were analyzed for Helios expression. A
C57Bl/6 mouse, pictured on the right, was used as a control. Cells in all panels are previously gated
on live CD45.1+ CD3+ cells. N=3 (adult), N=3 (fetal), N=3 (B6)
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Figure 16. Helios Expression in TCRab+ Splenocytes. Hematopoietic stem cells (HSCs) isolated
from either adult bone marrow (adult HSC transfer) or fetal (ED17.5/18.5) liver (fetal HSC
transfer) were retro-orbitally injected into RAG2 deficient mice. Confirmation of reconstitution was
done 6-8 weeks later through flow cytometry analysis confirming the presence of CD45.1+ cells.
Mice were then sacrificed, and their organs were analyzed for Helios expression. A C57Bl/6 mouse,
pictured on the right, was used as a control. Cells in all panels are previously gated on live CD45.1+
CD3+ cells. N=3 (adult), N=3 (fetal), N=3 (B6)
Our results however showed that Helios expression was observed in intestinal γδ T cells
after HSC transfer from both fetal liver and adult bone marrow (Figure 15). We also observed
similar levels of Helios expression in splenocytes after both fetal and adult HSC transfer (Figure
16). We initially isolated HSCs from embryonic day (ED) 17.5/18.5 fetal livers, but after
observing a similar phenotype to adult HSCs, we speculated that this age may be too late in
development to produce an accurate depiction of Helios expression in the fetus. Therefore, we
decided to repeat the experiment with HSCs isolated from ED 15 fetal livers instead, with the
hypothesis that HSCs from a less developed fetus may produce different Helios expression. We
observed that in the RAG2KO mice that had received fetal liver HSCs form ED15, Helios
expression was similar to both ED17.5/18.5 and adult HSCs (Figure 17).
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Figure 17. Gut gd T Cell Helios Expression after ED15 HSC Transfer to RAG2KO Mice.
Hematopoietic stem cells (HSCs) isolated from fetal (ED17.5/18.5) liver (fetal HSC transfer)
were retro-orbitally injected into RAG2 deficient mice. Confirmation of reconstitution was done
6-8 weeks later through flow cytometry analysis confirming the presence of CD45.1+ cells. Mice
were then sacrificed, and their organs were analyzed for Helios expression. A C57Bl/6 mouse was
used as a control. Cells in all panels are previously gated on live CD45.1+ CD3+ TCRgd+ cells.
N=3
These data suggest that Helios expression is not determined at the stem cell level. Instead,
we predict that there is either a specific subset of HSCs that become Helios+, or Helios is induced
by a specific environment such as in the intestines. If the latter is true, we would expect that a
subset of T cells in the intestines would express Helios after localization in the tissue.

CHAPTER FIVE
DISCUSSION
Three Distinct Groups of gd T Cells
gd T cells are a unique subset of immune cells that have multiple functions within our
bodies. With the ability to recognize both molecules associated with and without MHC90-95, gd T
cells provide a variety of responses. They can present with both a Th1 and a Th2 phenotype102104

, supporting the notion that these cells are functionally distinct from other T cells. With the

knowledge of gd T cells being multifunctional, we sought to expand our knowledge on this
subset through a barcoded single cell RNAseq experiment. From this, we identified 3 individual
subsets of TCRgd+ T cells within the intestines of C57Bl/6 mice. Each of the groups of gd’s
appeared to be functionally distinct from one another, as they all were found to have unique
differentially expressed genes. To explore this further, and potentially decipher functions of each
subset of gut gd T cells, we ran pathway analyses using data gathered from the scRNAseq
experiment.
Our pathway analysis results showed that these 3 groups appear to have key functional
differences that give insight into the role they are playing within the intestines. The first group of
gut gd T cells seem to play a role in the regulation of the immune defense response. With the
expression of genes like IL-2Rb and CD160, this group has the potential to act in a similar
manner to, or in the recruitment of, regulatory T cells. Since these cells were only identified in
the gut and not in the spleen, this regulation of immune response to antigens may be gut-specific
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of these gd T cells. A future direction regarding this subset of cells would be to look for similar
genes to that of Tregs, which they cells appear to be acting similar too. If none, it may also be
impactful to find markers specific to this cluster of gd’s in order to separate this group out for
further studies.
The second group of gd T cells that were identified appear to be important in the adaptive
immune response, as well as in the regulation of lymphocytic activation. This subset of gd’s,
unlike the first group, seem to be crucial in promoting activation of the immune response when
necessary, and the gut is responding to foreign antigens. What is interesting however, is that
typically we associated CD4+ T cells with this type of response, but our data from the barcoded
antibodies we included shows that this group, and neither of the other 2 gd subsets express CD4.
Instead, they all coexpress CD8a along with the TCRgd. Since the majority of intestinal gd’s that
we have observed are CD8aa, it may be possible that these different gd subsets are all coming
from CD8aa+ gd T cells. This group of gd’s also appears to have high expression of genes
controlling the response to corticotropin-releasing hormone (CRH). CRH is a key element in the
body’s response to stress, as well as is present in inflammatory diseases. This function brings up
the question of the role this subset of gd T cells is playing in gut stress response, which
potentially may be related to inflammatory diseases as well. If these cells were contributing to
the response of CRH, it may be important to be further studied in the context of inflammatory
bowel disease, since there may be dysregulation involving this subset of gd T cells.
The third group of gd T cells appear to be similar to the second group, in that they express
genes important for cell activation. They were also found to increase the immune defense
responses, with multiple genes associated with the recruitment of other immune cells, especially
neutrophils. Their propensity to drive neutrophils to a site of attack supports the idea that this
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group of gd T cells are promoting the immune response upon microbial exposure. It would be
important to test next if these cells produce high levels of IL-17, which promotes neutrophilic
activation.
The overall functions of gd T cells have been described by researchers previously,
however, there has not been research done on functionally distinct subsets within gd T cells. Our
data provides evidence for the concept of three unique gd T cell groups within the intestines that
are potentially interacting together, but with separate goals, to maintain homeostasis of the gut
environment. While the scRNAseq data and pathway analysis that was completed appear to
provide new information regarding unique subsets of gd T cells, it is important to note that our
attempt at confirming the differentially expressed genes within each subset through protein
analysis was not successful.
A Subset of Foxp3+ gd T Cells
The perinatal immune system is well recognized as existing in a highly tolerogenic state
due to the lack of mature immune responses. We wanted to further explore the mechanisms
behind how this state is achieved and maintained within the gut environment. To do this, we
looked at phenotypes from fetal (ED 17.5/18.5), neonatal (5-day old), and adult (6-8 weeks)
intraepithelial lymphocytes and lamina propria lymphocytes. Upon analysis, we discovered that a
new subset of T cells was present within the intestines of the fetal and neonatal mice that was not
present in the adult intestines. This subset coexpressed TCRgd with the heterodimer CD8ab.
Further analysis showed that this group of CD8ab+ TCRgd+ T cells in neonatal intestines only
had a small proportion of cells that were Foxp3+. Since Foxp3 is an important transcription factor
for Tregs, we hypothesized that this subset of cells may be playing a similar role within the fetal
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and neonatal intestines prior to the development of Tregs, which do not appear until about 3 days
after birth.
Since the newly identified subset of T cells, CD8ab+ TCRgd+, appeared to be a small
percentage of cells, we decided to further explore a potential function for them by looking more
broadly at Foxp3+ gd T cells. The only reports that have been published on Foxp3+ gd T cells
were looking at gd’s that had been induced in vitro with TGFb and IL-15. Due to their Foxp3
expression, we again hypothesized that these cells would have immunosuppressive effects. Some
of our previous screening efforts on intestinal T cells in other mouse strains, identified that OT-II
transgenic mice had high expression of Foxp3 in all subsets of gd T cells, which we confirmed
with flow cytometry. We hypothesize that this high Foxp3 expression may be due to a difference
in gd T cell development in OT-II mice. Our analysis shows that unlike wildtype B6 mice, the
OT-II intestinal gd T cells have low levels of Helios expression but significantly higher
expression of Foxp3.
Using the spleen and gut from these OT-II mice, we set up a suppression assay to assess
if the addition of Foxp3+ gd T cells would affect any proliferation after stimulation with antiCD3. Analysis of this experiment showed that addition of both OT-II splenic and gut Foxp3+ gd
T cells caused a substantial decrease in proliferation of CD45.1 T cells. These data support our
hypothesis, showing the potential for Foxp3+ gd T cells to have immunosuppressive effects.
However, these data would need to be repeated as this experiment has only been done once so
far. It would also be important to check if the decrease in proliferation is due to actual
immunosuppressive effects or if cytotoxicity played a factor, which could be done by looking at
granzyme expression.
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Fetal, Neonatal, and Adult IEL Helios Expression
The transcription factor Helios, encoded by the IKZF2 gene, was discovered by our lab to
be highly expressed in donated umbilical cord blood as well as in murine intestinal gd T cells.
Because Helios is important in Treg stability and suppression, we hypothesized that Helios may
play an important role in the maintenance of perinatal tolerance before Foxp3+ Tregs are present.
This led us to also propose that Helios will be more expressed in fetal and neonatal intestines
than in adult intestines, since Tregs are typically present in adult intestines to help maintain
tolerance.
Analysis of fetal, neonatal, and adult intestines showed that overall, the fetal IELs and
LPLs did indeed have the highest amount of Helios expression when compared to the other age
groups. However, both neonatal and adult LPL were shown to express high levels of Helios as
well, but its expression was significantly decreased in both of their IELs. To check for peripheral
expression of Helios, we analyzed the spleens from each age group. Again, the highest
expression of Helios was seen in the fetal spleens, but even this was significantly decreased from
what we see in the fetal intestines. This led us to conclude overall that Helios is important in the
development within the intestines but may play a lesser role elsewhere in the body. Helios+ gd T
cells may be functioning to maintain the perinatal tolerance that is extremely important for their
survival and proper development.
Fetal and Adult HSCs Promote Helios Expression
To try and further our knowledge on the origin of Helios, which would allow for a better
understanding of the transcription factor, we decided to test where its expression is coming from.
We hypothesized that Helios+ gd T cells in the intestines are originating from fetal HSCs and
their expression is maintained by self-renewal. Since we see a decrease in Helios expression in
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the periphery, we propose that these cells do not have this self-renewing property and therefore
lose their Helios expression over time. To test this, we transferred HSCs from the fetal liver and
adult bone marrow into RAG2KO mice. After waiting for adequate reconstitution of these cells,
we analyzed their organs to compare Helios expression. If our hypothesis was correct, we would
expect to see that only the mice that had received fetal liver HSCs would have Helios expression.
However, our results showed the opposite of this, and we observed Helios expression after both
fetal liver and adult bone marrow HSC transfer. These data tell us that Helios is not determined
at the stem cell level, but that there is instead a potentially specific subset of HSCs that become
positive for Helios. Another possibility for Helios expression is that it may be induced within
specific environments, such as the intestines after HSCs localize in the tissues.
Conclusion
In conclusion, the findings presented in this thesis contribute new knowledge to the field
of gd T cells and the transcription factor Helios. With the highly informative data received from
our barcoded single cell RNAsequencing experiment, 3 functionally unique subsets of gd’s were
identified. Further research into each subset and the identification of potential markers would be
an important next step. Along with this, a subset of Foxp3+ gd T cells has been identified and
evidence for them playing an immunosuppressive role was shown. To strengthen this finding
further, further rounds of the suppression assay would need to be completed and compared.
The research done regarding Helios expression and where it originates from contributes
to our understanding of this transcription factor. Its high prevalence in fetal and neonatal
intestines implies an important role for Helios in maintaining homeostasis, especially within the
intestines. While we do not have a conclusive answer regarding where Helios is originating from,
we were able to show that it does not originate from hematopoietic stem cells. There is still a lot
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to understand about Helios and its function in the immune system, however the data presented
furthers the current knowledge.
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